Venetoclax-Rituximab Treatment Of Relapsed/Refractory Cll During The Covid-19 Pandemic: A Real-Life Experience In Selected Central-Southern Italian Regions
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES（2021）
关键词
YY CLL, symptomatic COVID19, Venetoclax-rituximab, time-limited therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要